Tom Cruise rant on Covid rules was the right message delivered in the worst possible way nbcnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nbcnews.com Daily Mail and Mail on Sunday newspapers.
by Jim Shamp, NCBiotech writer December 17, 2020 .
RESEARCH TRIANGLE PARK – Dallas-based Taysha Gene Therapies announced plans today to invest $75 million in a gene therapy manufacturing facility in Durham that will employ more than 200 people.
Taysha is joining the fast-growing community of cutting-edge gene- and cell-therapy companies setting up shop in the Research Triangle, where decades of investment and workforce training have created a magnet for the discovery and manufacture of science’s game-changers in fighting some of humankind’s most fearsome maladies.
Taysha logo
The company is developing gene therapies that use benign adeno-associated viruses (AAV) as “vectors,” or carriers, to transport genetic corrections to otherwise defective areas of the body. Taysha is initially targeting genetic diseases of the central nervous system, such as CLN1 disease, also called infantile Batten disease, which causes developmental delays in children, and Rett syndrome, a
A top scientist questioned virus lockdowns on Fox News. The backlash was fierce.
Peter Jamison, The Washington Post
Dec. 16, 2020
FacebookTwitterEmail
The epidemiologist sitting before the cameras spoke with calm authority. It was late March, and as the coronavirus spread across the country, it came as no surprise that journalists were turning to John Ioannidis. The Stanford University medical professor was famous for his rigorous assessments - and frequent debunking - of disease treatments. He was a consummate physician-researcher, combining fluency in the mathematical models that predict a pathogen s lines of attack with experience at the bedsides of patients suffering from AIDS.
What is the protective value of different face masks?
Written by Timothy Huzar on December 16, 2020 Fact checked by Catherine Carver, MPH
Researchers have assessed how effective various medical and consumer-grade masks are at protecting the wearer from exposure to particles similar in size to SARS-CoV-2.
LIONEL BONAVENTURE/Getty Images
In a new study, scientists have analyzed how effective consumer-grade masks, medical masks, and modified medical masks are at protecting the wearer from particles of a similar size to SARS-CoV-2.
The research, which appears in the journal
JAMA Internal Medicine, provides more information for the public and clinicians on which masks to wear, and what modifications are likely to be effective.